The healthcare community is buzzing about Retatrutide 120 , a dual-action treatment showing impressive outcomes in early trials . This new compound, a GLP-1 receptor alongside a glucose-dependent insulinotropic compound, appears to effectively reduce body size and improve metabolic function . Res